Exploring Biliary Tract Cancer: Top Takeaways From ASCO GI 2025 - Episode 12
Panelists discuss how significant challenges remain in HER2-positive biliary tract cancer (BTC), including optimizing sequencing of targeted therapies, addressing resistance mechanisms, improving biomarker testing accessibility, and developing strategies for brain metastases.
Video content above is prompted by the following: